arrow
H

Hans Pottel

ku leuven
H指数:54
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Serological Method's Ability to Distinguish Treatment Regimens by Assessing Early Antibody Decline in Chagas Patients: Insights From E1224 Data

一种通过评估恰加斯病患者早期抗体下降来区分治疗方案血清学方法的能力:来自E1224数据的见解

2026-08-190
OAAI
Performance of creatinine and cystatin C-based equations for estimating high levels of glomerular filtration rate in Congolese adults with sickle cell disease

基于肌酐和胱抑素C的方程在估计刚果成人镰状细胞病患者高肾小球滤过率水平时的性能

2026-04-280
OA
Publisher Correction: Performance of creatinine and cystatin C-based equations to estimate glomerular filtration rate in African children with sickle cell anemia

出版商更正:基于肌酐和胱抑素C的方程在非洲镰状细胞贫血儿童中估算肾小球滤过率的表现

2025-11-100
PRE
Reference intervals for serum creatinine for healthy adults in central Africa: a post-hoc analysis

中非地区健康成年人血清肌酐的参考区间:一项事后分析

2025-10-300
OAAI
Performance of creatinine and cystatin C-based equations to estimate glomerular filtration rate in African children with sickle cell anemia

基于肌酐和胱抑素C的方程在非洲镰状细胞贫血儿童中估算肾小球滤过率的表现

2025-10-160
PRE
Changing from the CKD-EPI to the EKFC creatinine equation to estimate glomerular filtration rate in adults in a Northern European health system

将估算成人肾小球滤过率的方程从CKD-EPI切换为EKFC肌酐方程,应用于北欧健康体系。

2025-09-012
PRE
Erratum to “Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1248-1259]

勘误“基于肌酐和胱抑素C的方程估算GFR结果不一致”【肾脏国际报告第10卷第4期,2025年4月,第1248-1259页】

2025-05-170
OA
Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR

基于肌酐和胱抑素C的方程在估算GFR方面结果不一致

2025-01-010
OAAI
Comparison between the EKFC-equation and machine learning models to predict Glomerular Filtration Rate
2024-11-022
OAAI
Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium

成人碘海醇血浆清除率测量协议标准化: 欧洲肾脏功能协会的共识文件

2024-10-013
OAAI
Estimating glomerular filtration in young people
2024-08-283
OAAI